David W. Hough

Chief Medical Officer, Kuvatris Therapeutics, Inc.

Companies

Kuvatris Therapeutics, Inc.Chief Medical Officer Aug 16, 2023 to Mar 14, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kuvatris Therapeutics, Inc.5,905 shares²Mar 12, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 12, 2024Shares withheld for tax 1,452 shares at $0.69 of Kuvatris Therapeutics, Inc.²
Feb 21, 2024Shares withheld for tax 291 shares at $0.66 of Kuvatris Therapeutics, Inc.³
Oct 23, 2023Granted 100,000 shares of Kuvatris Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKuvatris Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARKuvatris Therapeutics, Inc. shares after the filing of Mar 12, 2024
3
SEC EDGARForm 4 filed Feb 23, 2024
4
SEC EDGARForm 4 filed Oct 24, 2023